NO985335L - 2,4-Diaminopyrimidinderivater - Google Patents
2,4-DiaminopyrimidinderivaterInfo
- Publication number
- NO985335L NO985335L NO985335A NO985335A NO985335L NO 985335 L NO985335 L NO 985335L NO 985335 A NO985335 A NO 985335A NO 985335 A NO985335 A NO 985335A NO 985335 L NO985335 L NO 985335L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- compounds
- substances
- lower alkyl
- drugs
- Prior art date
Links
- YAAWASYJIRZXSZ-UHFFFAOYSA-N pyrimidine-2,4-diamine Chemical compound NC1=CC=NC(N)=N1 YAAWASYJIRZXSZ-UHFFFAOYSA-N 0.000 title 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 3
- 229940079593 drug Drugs 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 2
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 abstract 1
- 125000005677 ethinylene group Chemical group [*:2]C#C[*:1] 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000004475 heteroaralkyl group Chemical group 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- -1 hydroxy, amino Chemical group 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96107739 | 1996-05-15 | ||
| PCT/EP1997/002355 WO1997043277A1 (fr) | 1996-05-15 | 1997-05-07 | Derives de 2,4-diaminopyrimidine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO985335D0 NO985335D0 (no) | 1998-11-16 |
| NO985335L true NO985335L (no) | 1999-01-15 |
Family
ID=8222784
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO985335A NO985335L (no) | 1996-05-15 | 1998-11-16 | 2,4-Diaminopyrimidinderivater |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US5866583A (fr) |
| EP (1) | EP0901488B1 (fr) |
| JP (1) | JP3098259B2 (fr) |
| KR (1) | KR100295509B1 (fr) |
| CN (1) | CN1098260C (fr) |
| AR (1) | AR007088A1 (fr) |
| AT (1) | ATE227282T1 (fr) |
| AU (1) | AU726416B2 (fr) |
| BR (1) | BR9709251A (fr) |
| CA (1) | CA2254117C (fr) |
| CO (1) | CO4840509A1 (fr) |
| CY (1) | CY2425B1 (fr) |
| CZ (1) | CZ364698A3 (fr) |
| DE (1) | DE69716901T2 (fr) |
| DK (1) | DK0901488T3 (fr) |
| ES (1) | ES2184089T3 (fr) |
| HR (1) | HRP970260A2 (fr) |
| IL (1) | IL126702A0 (fr) |
| MA (1) | MA24182A1 (fr) |
| NO (1) | NO985335L (fr) |
| NZ (1) | NZ332481A (fr) |
| PE (1) | PE78898A1 (fr) |
| PL (1) | PL330277A1 (fr) |
| PT (1) | PT901488E (fr) |
| TR (1) | TR199802331T2 (fr) |
| TW (1) | TW438796B (fr) |
| WO (1) | WO1997043277A1 (fr) |
| YU (1) | YU51498A (fr) |
| ZA (1) | ZA973984B (fr) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9808135A (pt) * | 1997-03-03 | 2000-03-28 | Hoffmann La Roche | 2 4 diamnopirimidas substituìdas |
| EP0966464B1 (fr) * | 1997-03-03 | 2003-05-28 | Basilea Pharmaceutica AG | 2,4,-diaminopyrimidines substitues |
| US6277860B1 (en) * | 1999-10-29 | 2001-08-21 | Pfizer Inc | Furopyridine antibacterials |
| US6544555B2 (en) | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
| US6541014B2 (en) | 2000-10-13 | 2003-04-01 | Advancis Pharmaceutical Corp. | Antiviral product, use and formulation thereof |
| US20020068078A1 (en) | 2000-10-13 | 2002-06-06 | Rudnic Edward M. | Antifungal product, use and formulation thereof |
| AU2004260636A1 (en) * | 2003-06-13 | 2005-02-10 | Arena Pharmaceuticals, Inc. | 5-substituted 2H-pyrazole-3-carboxylic acid derivatives as agonists for the nicotinic acid receptor RUP25 for the treatment of dyslipidemia and related diseases |
| WO2005016877A2 (fr) * | 2003-08-07 | 2005-02-24 | Merck & Co., Inc. | Carboxamides de pyrazole utilises comme inhibiteurs de la dehydrogenase-1 11-beta-hydroxysteroide |
| WO2005016278A2 (fr) | 2003-08-12 | 2005-02-24 | Advancis Pharmaceuticals Corporation | Antibiotique, utilisation et formulation associees |
| DE102005062987A1 (de) * | 2005-12-28 | 2007-07-05 | Grünenthal GmbH | Substituierte Propiolsäureamide und ihre Verwendung zur Herstellung von Arzneimitteln |
| BRPI0814758A2 (pt) * | 2007-08-03 | 2015-03-03 | Hoffmann La Roche | Piridinacarboxamida e derivados de benzamida como ligantes taar1 |
| BRPI0921097B8 (pt) * | 2008-11-21 | 2021-05-25 | Raqualia Pharma Inc | composto ou seu sal farmaceuticamente aceitável, intermediário do composto, composição farmacêutica e uso do composto |
| US8716280B2 (en) * | 2009-01-21 | 2014-05-06 | Basilea Pharmaceutica Ag | Bicyclic antibiotics |
| CN102753531B (zh) * | 2009-12-15 | 2015-07-01 | 拜尔农作物科学股份公司 | 制备1-烷基-/1-芳基-5-吡唑羧酸衍生物的方法 |
| PE20141050A1 (es) | 2011-04-05 | 2014-08-30 | Pfizer Ltd | Inhibidores de quinasa relacionados con pirrolo (2,3-d) pirimidina tropomiosina |
| DE102013208484B4 (de) | 2013-05-08 | 2018-04-26 | Wirtgen Gmbh | Vorrichtung zum Bearbeiten von Straßen- oder Bodenoberflächen, sowie Verfahren zum Lenken einer Straßenfräsmaschine |
| US12043601B2 (en) * | 2018-08-22 | 2024-07-23 | The Regents Of The University Of Colorado | N-substituted-1H-1,2,4-triazole-3-carboxamides, analogues thereof, and methods of treatment using same |
| AR117169A1 (es) * | 2018-11-28 | 2021-07-14 | Bayer Ag | (tio)amidas de piridazina como compuestos fungicidas |
| US20230192617A1 (en) * | 2020-05-19 | 2023-06-22 | Bayer Cropscience Aktiengesellschaft | Azabicyclic(thio)amides as fungicidal compounds |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3485840A (en) * | 1964-11-12 | 1969-12-23 | Hoffmann La Roche | 2,4-diamino - 5 - (2',4',5'-substituted benzyl) pyrimidines,intermediates and processes |
| US4515948A (en) * | 1973-09-12 | 1985-05-07 | Hoffmann-La Roche Inc. | 2,4-Diamino-5-(4-amino and 4-dimethylamino-3,5-dimethoxy benzyl)pyrimidines |
| US4013644A (en) * | 1976-03-15 | 1977-03-22 | G. D. Searle & Co. | [8 α(E), 13aβ]-5,8,13,13a-tetrahydro-2,3,10,11-tetramethoxy-8-(2-phenylethenyl)-6H-dibenzo[a,g]quinolizines and intermediates thereto |
| US4444770A (en) * | 1980-05-29 | 1984-04-24 | Bayer Aktiengesellschaft | New imidazoazole-alkenoic acid amide compounds, intermediate products for their production, their production, and their medicinal use |
| US4594199A (en) * | 1983-09-19 | 1986-06-10 | E. R. Squibb & Sons, Inc. | Method for making phosphinic acid intermediates |
| EP0639075A1 (fr) * | 1990-11-14 | 1995-02-22 | Chiron Corporation | Inhibition specifique de la dihydrofolate reductase et composes prevus a cet effet |
| CA2205406C (fr) * | 1994-11-24 | 2008-02-05 | F. Hoffmann-La Roche Ag | Nouvelles benzylpyrimidines |
| EP0832069B1 (fr) * | 1995-06-07 | 2003-03-05 | Pfizer Inc. | DERIVES DE BIPHENYL-2-ACIDE CARBOXYLIQUE-TETRAHYDRO-ISOQUINOLEINE-6-YL AMIDES, PREPARATION DE CES AMIDES ET UTILISATION EN TANT QU'INHIBITEURS DE LA PROTEINE DE TRANSFERT DE TRIGLYCERIDE MICROSOMAL ET/OU DE LA SECRETION D'APOLIPOPROTEINES B (Apo B) |
| EP1149834A1 (fr) * | 1995-12-04 | 2001-10-31 | F. Hoffmann-La Roche Ag | Diaminopyrimidines, compositions pharmaceutiques les contenant et utilisation de celles-ci en tant qu' agents antibactériens |
-
1997
- 1997-04-19 TW TW086105103A patent/TW438796B/zh active
- 1997-04-24 US US08/842,459 patent/US5866583A/en not_active Expired - Lifetime
- 1997-05-07 PT PT97923018T patent/PT901488E/pt unknown
- 1997-05-07 AU AU28942/97A patent/AU726416B2/en not_active Ceased
- 1997-05-07 KR KR1019980709204A patent/KR100295509B1/ko not_active Expired - Fee Related
- 1997-05-07 BR BR9709251A patent/BR9709251A/pt not_active IP Right Cessation
- 1997-05-07 CA CA002254117A patent/CA2254117C/fr not_active Expired - Fee Related
- 1997-05-07 CZ CZ983646A patent/CZ364698A3/cs unknown
- 1997-05-07 PE PE1997000356A patent/PE78898A1/es not_active Application Discontinuation
- 1997-05-07 JP JP09540486A patent/JP3098259B2/ja not_active Expired - Fee Related
- 1997-05-07 AT AT97923018T patent/ATE227282T1/de not_active IP Right Cessation
- 1997-05-07 IL IL12670297A patent/IL126702A0/xx unknown
- 1997-05-07 TR TR1998/02331T patent/TR199802331T2/xx unknown
- 1997-05-07 DE DE69716901T patent/DE69716901T2/de not_active Expired - Lifetime
- 1997-05-07 WO PCT/EP1997/002355 patent/WO1997043277A1/fr not_active Ceased
- 1997-05-07 DK DK97923018T patent/DK0901488T3/da active
- 1997-05-07 NZ NZ332481A patent/NZ332481A/xx unknown
- 1997-05-07 CN CN97194633A patent/CN1098260C/zh not_active Expired - Fee Related
- 1997-05-07 ES ES97923018T patent/ES2184089T3/es not_active Expired - Lifetime
- 1997-05-07 PL PL97330277A patent/PL330277A1/xx unknown
- 1997-05-07 EP EP97923018A patent/EP0901488B1/fr not_active Expired - Lifetime
- 1997-05-08 ZA ZA9703984A patent/ZA973984B/xx unknown
- 1997-05-12 AR ARP970101966A patent/AR007088A1/es unknown
- 1997-05-14 CO CO97025823A patent/CO4840509A1/es unknown
- 1997-05-15 MA MA24620A patent/MA24182A1/fr unknown
- 1997-05-15 HR HR96107739.3A patent/HRP970260A2/xx not_active Application Discontinuation
-
1998
- 1998-11-13 YU YU51498A patent/YU51498A/sr unknown
- 1998-11-16 NO NO985335A patent/NO985335L/no not_active Application Discontinuation
-
2004
- 2004-02-20 CY CY0400011A patent/CY2425B1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO985335L (no) | 2,4-Diaminopyrimidinderivater | |
| GB9801690D0 (en) | Therapeutic agents | |
| NO941937D0 (no) | Sakarinderivater som inhiberer proteolytiske enzymer | |
| AR050917A1 (es) | Compuestos basados en 2-amido-tiazol que presentan actividad inhibidora de enzimas que utilizan atp, y composiciones y usos de los mismos | |
| NO990667D0 (no) | Depeptid-benzamidin som kinogenase-inhibitor | |
| NO971471L (no) | Nye karboksamider med fungicid aktivitet | |
| NO20045369L (no) | Nye, substituerte sulfamatanticonvulsivaderivater | |
| IS6257A (is) | Frumuviðloðunartálmar | |
| FR2712591B1 (fr) | Nouvelles arylpipérazines dérivées d'indole, leur préparation et leur utilisation thérapeutique. | |
| DE69924292D1 (de) | Pyrazol verbindungen und ihre verwendung | |
| NO20000722L (no) | 2-(4-aryl eller heteroaryl-piperazin-1-ylmetyl)-1H- indolderivater | |
| NO20013684L (no) | Substituerte fenetylaminderivater | |
| NO20050666L (no) | 2,7-substituerte indoler og deres anvendelse som 5-HT6 modulatorer | |
| NO20022232L (no) | Imidazolforbindelser for anvendelse som inhibitorer for fosfodiesterase VII | |
| TR200001452T2 (tr) | Bifenilamidin türevleri. | |
| CA2302943A1 (fr) | Derives de phtalazine et agents therapeutiques contre la dyserection | |
| DK527984D0 (da) | 11-substituerede 5h,11h-pyrrolo(2,1-c)(1,4)benzoxazepiner eller farmaceutisk acceptable salte deraf, deres fremstilling og mellemprodukter hertil samt deres anvendelse som antipsychotika og analgetika | |
| NO964348L (no) | CCK- eller gastrin-modulerende 5-hetrocykliske-1,5-benzodiazepiner | |
| DK492288D0 (da) | Amidforbindelser, farmaceutisk praeparat indeholdende samme samt fremgangsmaade til fremstilling af forbindelserne | |
| DK0553016T3 (da) | Hidtil ukendte naphtalenamider og -sulfonamider, fremgangsmåder til deres fremstilling samt farmaceutiske midler indeholdende dem | |
| NO963331L (no) | 5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister | |
| NO20022123L (no) | Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII | |
| WO1998031704A3 (fr) | Antagonistes de tachykinine | |
| DK266686D0 (da) | 1-aryl-5-alkoximinoalkylaminopyrazoler, fremgangsmaader til fremstilling deraf og deres anvendelse som herbicider og vaekstregulatorer | |
| NO983439L (no) | 1-(pyrazol-3-yl-etyl)-4-(indol-3-yl)-piperidin anvendt som medisin som virker på sentralnervesystemet |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |